Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells

World J Gastroenterol. 2005 Sep 28;11(36):5638-43. doi: 10.3748/wjg.v11.i36.5638.

Abstract

Aim: To examine whether lysophosphatidic acid (LPA) induces phosphorylation of c-Met and epidermal growth factor receptor (EGFR), both of which have been proposed as prognostic markers of colorectal cancer, and whether LPA induces cyclooxygenase-2 (COX-2) expression in human colon cancer cells.

Methods: Using a human colon cancer cell line, LoVo cells, we performed immunoprecipitation analysis, followed by Western blot analysis. We also examined whether LPA induced COX-2 expression, by Western blot analysis.

Results: Immunoprecipitation analysis revealed that 10 micromol/L LPA induced tyrosine phosphorylation of c-Met and EGFR in LoVo cells within a few minutes. We found that c-Met tyrosine phosphorylation induced by LPA was not attenuated by pertussis toxin or a matrix metalloproteinase inhibitor, in marked contrast to the results for EGFR. In addition, 0.2-40 micromol/L LPA induced COX-2 expression in a dose-dependent manner.

Conclusion: Our results suggest that LPA acts upstream of various receptor tyrosine kinases (RTKs) and COX-2, and thus may act as a potent stimulator of colorectal cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Colonic Neoplasms / enzymology
  • Colonic Neoplasms / metabolism*
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase Inhibitors / pharmacology
  • Enzyme Induction / drug effects
  • ErbB Receptors / metabolism*
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Lysophospholipids / pharmacology*
  • Nitrobenzenes / metabolism
  • Phosphorylation
  • Proto-Oncogene Proteins c-met / metabolism*
  • Signal Transduction
  • Sulfonamides / metabolism
  • Transcriptional Activation / drug effects*
  • Up-Regulation / drug effects

Substances

  • Cyclooxygenase Inhibitors
  • Lysophospholipids
  • Nitrobenzenes
  • Sulfonamides
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Cyclooxygenase 2
  • ErbB Receptors
  • Proto-Oncogene Proteins c-met
  • lysophosphatidic acid